Yarrow Bioscience (YARW) Change in Cash (2017 - 2026)

Yarrow Bioscience (YARW) has 10 years of Change in Cash data on file, last reported at $604000.0 in Q1 2026.

• Quarterly Change in Cash fell 92.71% year-over-year to $604000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (down 30.34% YoY) and the FY2025 annual result came in at $4.1 million, up 138.16% from the prior year.
• Change in Cash improved to $604000.0 in Q1 2026, from -$6.2 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $15.2 million in Q4 2023 to a low of -$13.3 million in Q3 2024.
• A 5-year average of -$1.3 million and a median of -$4.6 million in 2022 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2023 — Change in Cash soared 429.68% — and 2024, when it tumbled 1562.59%.
• Tracing YARW's Change in Cash over 5 years: stood at -$4.6 million in 2022, then soared by 429.68% to $15.2 million in 2023, then plunged by 76.23% to $3.6 million in 2024, then sank by 270.83% to -$6.2 million in 2025, then jumped by 109.8% to $604000.0 in 2026.
• The last three Change in Cash figures came in at $604000.0 (Q1 2026), -$6.2 million (Q2 2025), and $8.3 million (Q1 2025), per Business Quant data.